Strontium Ranelate Market

As an Anti osteoporosis drugs, Strontium Ranelate is mainly used for the treatment and prevention of postmenopausal women with osteoporosis, significantly reduce the risk of vertebral fractures and hip fractures.
Drug interactions of Strontium Ranelate:

Food, milk, dairy products and calcium containing preparations can reduce the bioavailability of strontium ranelate by 60% ~ 70%. Therefore, strontium ranelate should be taken with these substances at an interval of more than 2 hours. Since divalent cations can combine with oral tetracycline and quinolone antibiotics in the gastrointestinal tract to form complexes, thus reducing their absorption, strontium ranelate should not be taken with these drugs. As a precaution, strontium ranelate should be stopped when taking tetracycline and quinolones orally.
Strontium Ranelate Market contains market size and forecasts of Strontium Ranelate in global, including the following market information:
Global Strontium Ranelate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Strontium Ranelate Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Strontium Ranelate companies in 2021 (%)
The global Strontium Ranelate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Strontium Ranelate include AbMole BioScience, American Elements, BioCrick BioTech, Combi-Blocks Inc, Fengchen Group, Hefei Home Sunshine Pharmaceutical Technology, Pharmaffiliates and Watson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Strontium Ranelate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Strontium Ranelate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Strontium Ranelate Market Segment Percentages, by Type, 2021 (%)
Purity 98%
Purity 99%
Global Strontium Ranelate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Strontium Ranelate Market Segment Percentages, by Application, 2021 (%)
Medicine
Chemical
Other
Global Strontium Ranelate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Strontium Ranelate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Strontium Ranelate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Strontium Ranelate revenues share in global market, 2021 (%)
Key companies Strontium Ranelate sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Strontium Ranelate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbMole BioScience
American Elements
BioCrick BioTech
Combi-Blocks Inc
Fengchen Group
Hefei Home Sunshine Pharmaceutical Technology
Pharmaffiliates
Watson